CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Recruiting · NCT06238765 · Observational (researchers observe without assigning treatment) · Lead sponsor: CorEvitas
View the official record on ClinicalTrials.gov →What this trial is about
Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.
Who can take part
Age range
10 Years to 15 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- To be eligible to participate in this registry, an individual must meet all the following criteria:
- Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified healthcare provider
- Is 10 - 15 years of age at the time of enrollment.
- Subject has initiated or is initiating an enrollment-eligible medication at the time of enrollment
Exclusion criteria
- An individual who meets any of the following criteria will be excluded from participation in the registry:
- Is participating or planning to participate in a blinded clinical trial for an AD drug.
- Is unwilling or unable to provide standing height measurements.
Where it is running
1 location listed across 1 US state.
- CorEvitas, LLC - Waltham, Massachusetts, United States